Alere declares cash dividend of $3.00 per share

Alere Inc. (NYSE: ALR), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend is payable on April 15, 2013 to holders of record of Series B stock at the close of business on April 1, 2013. 

Such payment will cover the amount of all dividends accrued from January 1, 2013 through March 31, 2013.

By developing new capabilities in near-patient diagnosis, monitoring and health information solutions, Alere enables individuals to take charge of improving their health and quality of life at home.  Alere's global leading products and services, as well as its new product development efforts, focus on cardiology, infectious disease, toxicology and diabetes.  Alere is headquartered in Waltham, Massachusetts.

Source:

Alere Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Alere Inc.. (2019, June 20). Alere declares cash dividend of $3.00 per share. News-Medical. Retrieved on December 09, 2019 from https://www.news-medical.net/news/20130302/Alere-declares-cash-dividend-of-24300-per-share.aspx.

  • MLA

    Alere Inc.. "Alere declares cash dividend of $3.00 per share". News-Medical. 09 December 2019. <https://www.news-medical.net/news/20130302/Alere-declares-cash-dividend-of-24300-per-share.aspx>.

  • Chicago

    Alere Inc.. "Alere declares cash dividend of $3.00 per share". News-Medical. https://www.news-medical.net/news/20130302/Alere-declares-cash-dividend-of-24300-per-share.aspx. (accessed December 09, 2019).

  • Harvard

    Alere Inc.. 2019. Alere declares cash dividend of $3.00 per share. News-Medical, viewed 09 December 2019, https://www.news-medical.net/news/20130302/Alere-declares-cash-dividend-of-24300-per-share.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Alere i RSV test receives FDA CLIA waiver for detection of RSV infection in children, adults